Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Phoenix location
Access macular degeneration specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
Check if you qualify for this macular degeneration clinical trial in Phoenix, AZ
No-Cost Study Care
Local to Phoenix
Convenient for AZ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a Phase 1/Phase 2 multicenter study to evaluate the safety and efficacy of a one-time single-eye intravitreal dose of SAR402663 in participants with neovascular age-related macular degeneration. Participants will be enrolled in one of 2 parts: * In Part I (dose escalation), multiple dose levels of SAR402663 will be evaluated in successive cohorts of participants * In Part II (dose expansion), participants will be randomized to receive one of two dose levels selected based on data from
Sponsor: Sanofi
Yes, this clinical trial (NCT06660667) has an active research site in Phoenix, AZ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for macular degeneration treatment options in Phoenix, AZ, this clinical trial (NCT06660667) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all macular degeneration clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Phoenix — not just this study.
Browse Rheumatoid Arthritis Trials in Phoenix →